Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of Cancer
Anticancer Research · 2025
DOI: 10.21873/anticanres.17771 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Byung Mo Kang und 8 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Carbon-Sulfur Lyases, Fibroblasts, Methionine, Recombinant Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AntiCancer Inc., San Diego, CA, U.S.A.
- Department of Surgery, University of California, San Diego, CA, U.S.A.
- Department of Surgery, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Republic of Korea.
- AntiCancer Inc., San Diego, CA, U.S.A.; meishale@gmail.com.
Zitieren
APA
Kang, B. M., Han, Q., Li, S., Kim, J. S., Mizuta, K., Asano, Y., Miyashi, Y., Bouvet, M., & Hoffman, R. M. (2025). Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17771
Vancouver
Kang BM, Han Q, Li S, Kim JS, Mizuta K, Asano Y, et al. Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17771
BibTeX
@article{Kang2025,
author = {Kang, Byung Mo and Han, Qinghong and Li, Shukuan and Kim, Jin Soo and Mizuta, Kohei and Asano, Yohei and Miyashi, Yuta and Bouvet, Michael and Hoffman, Robert M},
title = {Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of Cancer},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17771}
}
EUVIMED